Dr. Reddy's, in the middle of COVID-19 vaccine tests, shut key plants across the global after detecting a cyberattack. Taisho signed on Insilico Medicine to identify new molecules against senescent cells for age-related diseases. India's Gland Pharma could be the first Chinese-owned Indian company to go public in India after authorities signed off on its IPO plan. And more.
Dr. Reddy’s Laboratories has isolated all data center services after detecting a cyberattack. Key plants in the U.S., U.K., Brazil, India and Russia were shut, The Economic Times reported. The incident comes just as the Indian generics marker is gearing up for a phase 2/3 trial of Russia’s COVID-19 vaccine, dubbed Sputinik V, after gaining the go-ahead from Indian regulators last week.
Taisho Pharmaceutical has tapped artificial intelligence drug discovery shop Insilico Medicine to identify new drugs against senescent cells, a newly emerged target that scientists believe can be used to combat age-related diseases. Insilico will be responsible for early target identification, while the Japanese company will validate the computer-generated compounds through in vitro and in vivo testing.
3. Fosun-owned Gland Pharma gets India nod for $816M IPO (Moneycontrol)
Gland Pharma has won clearance from the Securities and Exchange Board of India for its Rs.6,000 crore ($816 million) IPO, Moneycontrol reported, citing people familiar with matter. The Indian injectables manufacturer is 74% owned by China’s Fosun Pharma. The listing would mark the first major IPO by an Chinese-owned Indian company, even as tensions between the two countries grow.
Samsung Biologics has grown sales by 49% year over year to KRW 89.8 billion ($80 million) in the third quarter, thanks to a “continuous increase in sales volume across all plants.” Meanwhile, Biogen’s biosimilars business, which is supported by its Samsung joint venture Samsung Bioepis, grew sales by 13% to $208 million in Q3. The Korean CDMO in August unveiled plans for a major fourth plant.
Lockdowns and fear of infection have created a mental health crisis spinning out of the COVID-19 pandemic. To address that crisis, Otsuka’s U.S. division has launched a YouTube series and a national youth mental health initiative. The “Building Mental Resiliency” series on YouTube has 17 videos offering advice and resources for managing mental health.